Pulse Biosciences (PLSE) vs Warby Parker (WRBY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Pulse Biosciences (PLSE) has outperformed Warby Parker (WRBY) over the past year, gaining 179.5% versus a gain of 6.6%. Over five years, PLSE leads with a +148.5% price change compared with -53.8% for WRBY. Pulse Biosciences is the larger company by market cap ($3.84 billion vs $3.13 billion), about 1.2 times the size.
Warby Parker converts more of its revenue into profit, with a net margin of 0.2% versus -20794.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PLSE | WRBY |
|---|---|---|
| Share price | $53.81 | $25.30 |
| Market cap | $3.84B | $3.13B |
| 1-day change | +7.66% | +1.40% |
| YTD return | +291.92% | +16.11% |
| 1-year return | +179.53% | +6.57% |
| 5-year return | +148.55% | -53.79% |
| P/E ratio (TTM) | — | 421.67 |
| Forward P/E | — | 41.15 |
| EPS (TTM) | $-1.18 | $0.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $350.00K | $871.90M |
| Revenue growth (YoY) | — | +13.04% |
| Net income (latest FY) | $-72.78M | $1.64M |
| Gross margin | -54.00% | 53.97% |
| Operating margin | -21982.57% | -0.61% |
| Net margin | -20794.57% | 0.19% |
| 52-week high | $58.90 | $31.00 |
| 52-week low | $12.56 | $14.96 |
| Distance from 52-week high | -8.64% | -18.39% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +5.00% | +20.40% |
| Average volume | 506.70K | 2.87M |
| Shares outstanding | 71.32M | 108.24M |
| Employees | 116 | 2,275 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Ophthalmic Goods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PLSE has outperformed WRBY by 173.0 percentage points over the past year.
- Warby Parker is more profitable, keeping 0.2 cents of every revenue dollar as net income versus -20794.6 cents for Pulse Biosciences.
About Pulse Biosciences
PLSE stock →Pulse Biosciences, Inc. operates as a novel bioelectric medicine company.
Health Care · Medical/Dental Instruments · 116 employees
About Warby Parker
WRBY stock →Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada.
Health Care · Ophthalmic Goods · 2,275 employees
PLSE vs WRBY FAQ
Which is bigger, Pulse Biosciences or Warby Parker?
Pulse Biosciences (PLSE) is larger, with a market capitalization of $3.84B compared with $3.13B for Warby Parker (WRBY).
Which stock has performed better over the past year, PLSE or WRBY?
PLSE returned +179.53% over the past 12 months, compared with +6.57% for WRBY (price return, excluding dividends). Past performance does not predict future results.
Are Pulse Biosciences and Warby Parker in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Pulse Biosciences and Ophthalmic Goods for Warby Parker.